Thrombocytopenia with rituximab treatment--splenomegaly as the risk factor

Ann Hematol. 2010 Jan;89(1):95-6. doi: 10.1007/s00277-009-0768-9. Epub 2009 Jun 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Fatal Outcome
  • Female
  • Humans
  • Risk Factors
  • Rituximab
  • Splenomegaly / chemically induced*
  • Splenomegaly / diagnosis*
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab